KLHL11 Inhibitors

KLHL11 inhibitors are a class of chemical compounds designed to target and modulate the activity of the KLHL11 protein. KLHL11, or Kelch-like protein 11, is a member of the Kelch-like family of proteins, which are characterized by their involvement in protein-protein interactions. These proteins contain a BTB (Broad-Complex, Tramtrack, and Bric-à-brac) domain, which facilitates protein dimerization, and a Kelch domain, responsible for binding to specific substrates. The primary function of KLHL11, like many Kelch family proteins, is to act as a substrate adaptor in Cullin-RING ubiquitin ligase (CRL) complexes, which are involved in the ubiquitination and subsequent proteasomal degradation of target proteins. KLHL11 inhibitors disrupt these interactions, preventing the degradation of substrates that would otherwise be marked for destruction by the ubiquitin-proteasome system.

By inhibiting KLHL11, these compounds allow for the accumulation of specific proteins that KLHL11 targets for degradation. This process can lead to changes in cellular homeostasis, affecting a range of cellular processes such as signal transduction, cell cycle regulation, and protein turnover. Inhibitors of KLHL11 are particularly useful in studying the role of ubiquitination in various biological pathways. They serve as valuable tools in dissecting the mechanisms through which KLHL11 exerts control over specific substrates and contribute to our understanding of how ubiquitin ligases regulate cellular function. These inhibitors can be chemically diverse, ranging from small molecules that directly bind to the BTB or Kelch domains of KLHL11, to larger molecules that interfere with the assembly of the entire CRL complex.